155 results on '"Iwaki, Norio"'
Search Results
2. In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2018–19 season: Comparison with the 2010–11 to 2017–18 seasons
3. In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2016–17 season: Comparison with the 2010–11 to 2015–16 seasons
4. Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate in the 2016/17 Japanese influenza season; comparison with the 2011/12 to 2015/16 seasons
5. Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate; comparison of the 2011/12 to 2015/16 Japanese influenza seasons
6. In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2015–16 season: Comparison with the 2010–11 to 2014–15 seasons
7. Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate for influenza treatment; comparison among the four Japanese influenza seasons from 2011–2012 to 2014–2015
8. In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors against clinical isolates of the influenza viruses circulating in the 2010–2011 to 2014–2015 Japanese influenza seasons
9. Clinical outcome of laninamivir octanoate hydrate for influenza in the 2013–2014 Japanese season
10. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013–2014 season
11. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012–2013 season
12. Continued effectiveness of laninamivir octanate hydrate for influenza treatment in Japan: Comparison between the 2011–2012 and 2012–2013 influenza seasons
13. The duration of fever and other symptoms after the initiation of laninamivir octanoate hydrate in the Japanese 2011–2012 influenza season
14. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011–2012 season in Japan
15. Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009–2010 season: a comparison with seasonal H1N1 with or without H275Y mutation
16. Clinical Effectiveness of Oseltamivir and Zanamivir for Treatment of Influenza A Virus Subtype H1N1 with the H274Y Mutation: A Japanese, Multicenter Study of the 2007–2008 and 2008–2009 Influenza Seasons
17. Comparison of the Effectiveness of Zanamivir and Oseltamivir against Influenza A/H1N1, A/H3N2, and B
18. Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007–2008 and 2008–2009 seasons
19. Susceptibility of epidemic viruses to neuraminidase inhibitors and treatment-emergent resistance in the Japanese 2019-20 influenza season
20. Duration of fever and PA/I38X-substituted virus emergence in patients treated with baloxavir in the 2018–2019 influenza season
21. A change in the effectiveness of amantadine for the treatment of influenza over the 2003–2004, 2004–2005, and 2005–2006 influenza seasons in Japan
22. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season
23. Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010–2011 season: comparison with the previous season and with seasonal A(H3N2) and B
24. Susceptibility of epidemic viruses to neuraminidase inhibitors and treatment-emergent resistance in the Japanese 2019-20 influenza season.
25. The post-infection outcomes of influenza and acute respiratory infection in patients above 50 years of age in Japan: an observational study
26. In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2017–18 season: Comparison with the 2010–11 to 2016–17 seasons
27. Transmission of pandemic H1N1 2009 influenza in households and school settings: comparison with seasonal influenza
28. Usefulness of a self-blown nasal discharge specimen for use with immunochromatography based influenza rapid antigen test
29. Duration of fever and other symptoms after laninamivir octanoate hydrate inhalation over eight influenza seasons
30. A prospective, Internet-based study of the effectiveness and safety of influenza vaccination in the 2001–2002 influenza season
31. Effects of School-based Smoking Prevention Education by Physician After Eight Years: A School Randomized Controlled Trial
32. Smoking prevention class by physicians reduced smoking rates after 8 years
33. Prevalence of influenza B during the 2004 - 2005 season in Japan
34. Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010–2011 season: comparison with the previous season and with seasonal A(H3N2) and B
35. In vitro neuraminidase inhibitory concentration (IC 50 ) of four neuraminidase inhibitors in the Japanese 2015–16 season: Comparison with the 2010–11 to 2014–15 seasons
36. Comparison of the Kinetics of Granulocytes and Lymphocytes between Influenza A/H1N1/pdm 09 and Seasonal Influenza A
37. The post-infection outcomes of influenza and acute respiratory infection in patients above 50 years of age in Japan: an observational study
38. Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation
39. IF-03 Clinical Effectiveness of Oseltamivir or Zanamivir for Influenza A/H1N1 Virus with or without H274Y Mutation
40. Zanamivir treatment is equally effective for both influenza A and influenza
41. Detection of Respiratory Syncytial Virus with Nested RT-PCR and a New Rapid Detection Test Kit in Patients with Influenza-like Illness, Including Elderly Adults
42. A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B
43. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir
44. Effects of antiviral drugs on viral detection in influenza patients and on the sequential infection to their family members—serial examination by rapid diagnosis (Capilia) and virus culture
45. An Analysis of the 2002-2003 Influenza Epidemic Focusing on Patients Infected with Types A and B in the Same Season Sequentially
46. Clinical Symptoms of Influenza Infection in the 2002-2003 Season
47. Effectiveness of Oseltamivir on Influenza and Influencing Factors
48. A Comparison of the Effectiveness of Oseltamivir for the Treatment of Influenza A and Influenza B: A Japanese Multicenter Study of the 2003-2004 and 2004-2005 Influenza Seasons.
49. AN AUTOPSY CASE OF BEHCET'S SYNDROME ASSOCIATED WITH PULMONARY ARTERITIS AND TUBERCULOSIS
50. Studies on the Role of Vascular Permeability Factors of Polymorphonuclear Leukocytes in the Development of Vascular Injuris
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.